AmCham-IMSS deal pledges US $44 million to bring clinical trials to Mexican public hospitals
Source ↗
👁 0
💬 0
The Mexican Social Security Institute (IMSS) and the American Chamber of Commerce of Mexico (AmCham) have signed an agreement to increase sponsored clinical research in public hospitals, with a projected investment exceeding 766 million pesos (US $44 million) during the 2026–2030 period.
The agreement aims to have more pharmaceutical industry clinical trials conducted within IMSS’s hospital network. The project involves the IMSS Foundation, AmCham, and the pharmaceutical companies Amgen, AstraZ
The agreement aims to have more pharmaceutical industry clinical trials conducted within IMSS’s hospital network. The project involves the IMSS Foundation, AmCham, and the pharmaceutical companies Amgen, AstraZ
Comments (0)